343 related articles for article (PubMed ID: 22298767)
1. Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
Zhu NL; Asahina K; Wang J; Ueno A; Lazaro R; Miyaoka Y; Miyajima A; Tsukamoto H
J Biol Chem; 2012 Mar; 287(13):10355-10367. PubMed ID: 22298767
[TBL] [Abstract][Full Text] [Related]
2. The Necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor gamma repression in hepatic stellate cells.
Zhu NL; Wang J; Tsukamoto H
J Biol Chem; 2010 Oct; 285(40):30463-71. PubMed ID: 20663865
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
4. Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation.
Pan RL; Wang P; Xiang LX; Shao JZ
J Biol Chem; 2011 Apr; 286(14):12340-8. PubMed ID: 21239501
[TBL] [Abstract][Full Text] [Related]
5. Morphogens and hepatic stellate cell fate regulation in chronic liver disease.
Tsukamoto H; Zhu NL; Wang J; Asahina K; Machida K
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):94-8. PubMed ID: 22320925
[TBL] [Abstract][Full Text] [Related]
6. Pigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor.
Tsai TH; Shih SC; Ho TC; Ma HI; Liu MY; Chen SL; Tsao YP
PLoS One; 2014; 9(4):e95443. PubMed ID: 24763086
[TBL] [Abstract][Full Text] [Related]
7. Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor γ in hepatic stellate cells for their antifibrotic effect.
Yang MD; Chiang YM; Higashiyama R; Asahina K; Mann DA; Mann J; Wang CC; Tsukamoto H
Hepatology; 2012 Apr; 55(4):1271-81. PubMed ID: 22095555
[TBL] [Abstract][Full Text] [Related]
8. Curcumin regulates delta-like homolog 1 expression in activated hepatic stellate cell.
Qiu J; Zhou Q; Zhai X; Jia X; Zhou Y
Eur J Pharmacol; 2014 Apr; 728():9-15. PubMed ID: 24534491
[TBL] [Abstract][Full Text] [Related]
9. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis.
Cheng JH; She H; Han YP; Wang J; Xiong S; Asahina K; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G39-49. PubMed ID: 18006602
[TBL] [Abstract][Full Text] [Related]
10. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
12. EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis.
Yang Y; Chen XX; Li WX; Wu XQ; Huang C; Xie J; Zhao YX; Meng XM; Li J
J Cell Mol Med; 2017 Oct; 21(10):2317-2328. PubMed ID: 28332284
[TBL] [Abstract][Full Text] [Related]
13. Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells.
Kweon SM; Chi F; Higashiyama R; Lai K; Tsukamoto H
PLoS One; 2016; 11(5):e0156111. PubMed ID: 27214381
[TBL] [Abstract][Full Text] [Related]
14.
Yan J; Hu B; Shi W; Wang X; Shen J; Chen Y; Huang H; Jin L
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G720-G728. PubMed ID: 33728992
[TBL] [Abstract][Full Text] [Related]
15. Activation of PPARγ/P53 signaling is required for curcumin to induce hepatic stellate cell senescence.
Jin H; Lian N; Zhang F; Chen L; Chen Q; Lu C; Bian M; Shao J; Wu L; Zheng S
Cell Death Dis; 2016 Apr; 7(4):e2189. PubMed ID: 27077805
[TBL] [Abstract][Full Text] [Related]
16. RSPOs facilitated HSC activation and promoted hepatic fibrogenesis.
Yin X; Yi H; Wang L; Wu W; Wu X; Yu L
Oncotarget; 2016 Sep; 7(39):63767-63778. PubMed ID: 27572318
[TBL] [Abstract][Full Text] [Related]
17. Delta-like homolog1/GATA binding protein 2 axis mediates leptin inhibition of PPARγ2 expression in hepatic stellate cells in vitro.
Cheng Y; Zhu X; Cheng F; Ji L; Zhou Y
Life Sci; 2018 Jan; 192():183-189. PubMed ID: 29197497
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
[TBL] [Abstract][Full Text] [Related]
19. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ.
Du Z; Liu M; Wang Z; Lin Z; Feng Y; Tian D; Xia L
Cell Prolif; 2021 Jul; 54(7):e13072. PubMed ID: 34031939
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
